Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Top Cited Papers
- 1 January 2011
- Vol. 69 (2) , 203-213
- https://doi.org/10.1016/j.neuron.2011.01.002
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging InitiativeArchives of Neurology, 2011
- Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly PeopleArchives of Neurology, 2010
- Ginkgo biloba for Preventing Cognitive Decline in Older AdultsA Randomized TrialJAMA, 2009
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound BArchives of Neurology, 2009
- Targeting Aβ and tau in Alzheimer's disease, an early interim reportExperimental Neurology, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- Ginkgo biloba for Prevention of DementiaA Randomized Controlled TrialJAMA, 2008
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway HypothesisNeuron, 2008
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006